These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37460606)

  • 21. Additional stem cell therapy for graft failure after allogeneic bone marrow transplantation.
    Min CK; Kim DW; Lee JW; Min WS; Kim CC
    Acta Haematol; 2000; 104(4):185-92. PubMed ID: 11279309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy and safety analysis of umbilical cord blood combined with haploid hematopoietic stem cell transplantation in the treatment of malignant hematological malignancies].
    Yuan FF; Fu YW; Zhao MY; Li MH; Li GP; Wei XD
    Zhonghua Yi Xue Za Zhi; 2023 Sep; 103(35):2778-2785. PubMed ID: 37723052
    [No Abstract]   [Full Text] [Related]  

  • 23. T-cell replete haploidentical donor transplantation using post-transplant CY: an emerging standard-of-care option for patients who lack an HLA-identical sibling donor.
    Bashey A; Solomon SR
    Bone Marrow Transplant; 2014 Aug; 49(8):999-1008. PubMed ID: 24842530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Matched Family versus Alternative Donor Hematopoietic Stem Cell Transplantation for Patients with Thalassemia Major: Experience from a Tertiary Referral Center in South India.
    Swaminathan VV; Uppuluri R; Patel S; Ravichandran N; Ramanan KM; Vaidhyanathan L; Ramakrishnan B; Jayakumar I; Raj R
    Biol Blood Marrow Transplant; 2020 Jul; 26(7):1326-1331. PubMed ID: 32200123
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Child With Dyserythropoietic Anemia and Megakaryocyte Dysplasia Due to a Novel 5'UTR GATA1s Splice Mutation.
    Zucker J; Temm C; Czader M; Nalepa G
    Pediatr Blood Cancer; 2016 May; 63(5):917-21. PubMed ID: 26713410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-type bone marrow aplasia following hematopoietic stem cell transplantation in a child with a novel
    Wimalachandra M; Dissanayake R; Raj R; Kulasekeraraj A; Samarasinghe S; Gooneratne L
    Hematology; 2024 Dec; 29(1):2337160. PubMed ID: 38597819
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation for bone marrow failure: current issues.
    Peffault de Latour R
    Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):90-98. PubMed ID: 27913467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Case Report: A Child With Hemophilia A Serves as Donor for Hematopoietic Stem Cell Transplantation to Cure His Brother's Severe Aplastic Anemia.
    Kertész G; Kállay K; Kassa C; Zombori M; Bodó I; Kiss C; Szegedi I; Kriván G
    Pathol Oncol Res; 2022; 28():1610171. PubMed ID: 35755418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement.
    Taniguchi R; Muramatsu H; Okuno Y; Suzuki K; Obu S; Nakatochi M; Shimamura T; Takahashi Y; Horikoshi Y; Watanabe K; Kojima S
    Pediatr Blood Cancer; 2018 Feb; 65(2):. PubMed ID: 28921816
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic stem cell transplantation in two brothers with DNA ligase IV deficiency: a case report and review of the literature.
    Schober S; Schilbach K; Doering M; Cabanillas Stanchi KM; Holzer U; Kasteleiner P; Schittenhelm J; Schaefer JF; Mueller I; Lang P; Handgretinger R
    BMC Pediatr; 2019 Oct; 19(1):346. PubMed ID: 31604460
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing haematological recovery after allogeneic haemopoietic stem cell transplants: graft-versus-host disease, donor type, cytomegalovirus infections and cell dose.
    Dominietto A; Raiola AM; van Lint MT; Lamparelli T; Gualandi F; Berisso G; Bregante S; Frassoni F; Casarino L; Verdiani S; Bacigalupo A
    Br J Haematol; 2001 Jan; 112(1):219-27. PubMed ID: 11167808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation.
    Freson K; Devriendt K; Matthijs G; Van Hoof A; De Vos R; Thys C; Minner K; Hoylaerts MF; Vermylen J; Van Geet C
    Blood; 2001 Jul; 98(1):85-92. PubMed ID: 11418466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Analysis of risk factors for secondary cytopenia after allogeneic hematopoietic stem cell transplantation].
    Lin Z; Kong Y; Wang Y; Zhang X; Liu D; Xu L; Huang X
    Zhonghua Xue Ye Xue Za Zhi; 2014 Jan; 35(1):4-8. PubMed ID: 24602722
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hematopoietic Cell Transplantation for Congenital Dyserythropoietic Anemia: A Report from the Pediatric Transplant and Cellular Therapy Consortium.
    Rangarajan HG; Stanek JR; Abdel-Azim H; Modi A; Haight A; McKinney CM; McKeone DJ; Buchbinder DK; Katsanis E; Abusin GA; Ahmed I; Law J; Silva JG; Mallhi KK; Burroughs LM; Shah N; Shaw PJ; Greiner R; Shenoy S; Pulsipher MA; Abu-Arja R
    Transplant Cell Ther; 2022 Jun; 28(6):329.e1-329.e9. PubMed ID: 35288346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [GATA1-mutation associated leukemia in children with trisomy 21 mosaic].
    Reinhardt D; Reinhardt K; Neuhoff C; Sander A; Klusmann JH; Pekrun A; Sauerbrey A; von Stackelberg A; Rössig C; Creutzig U; Kolenova A
    Klin Padiatr; 2012 Apr; 224(3):153-5. PubMed ID: 22513796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome of allogeneic Hematopoietic Stem Cell Transplantation on Diamond-Blackfan anemia using busulfan-based myeloablative regimen.
    Behfar M; Koochakzadeh L; Yazdanian N; Salajegheh P; Rostami T; Khodayari-Namini N; Ghavamzadeh A; Hamidieh AA
    Turk J Pediatr; 2019; 61(3):407-412. PubMed ID: 31916719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogenic Hematopoietic Stem Cell Transplant in Iranian Patients With Congenital Sideroblastic Anemia: A Single-Center Experience.
    Shamsian BS; Jafari MR; Abolghasemi H; Eshghi P; Ehsani MA; Shahgholi E; Kazemi Aghdam M; Latifi A; Jamee M
    Exp Clin Transplant; 2023 Jan; 21(1):70-75. PubMed ID: 36757170
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and security of matched unrelated donor hematopoietic stem cell transplant with transfusion of multipotent mesenchymal cells in pediatric severe aplastic anemia].
    Wang L; Wang HX; Zhu L; Zheng XL; Wang ZD; Yan HM; Ding L; Han DM
    Zhonghua Xue Ye Xue Za Zhi; 2016 Jun; 37(6):453-7. PubMed ID: 27431066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of the Gata1 gene IE exon leads to variant transcript expression and the production of a GATA1 protein lacking the N-terminal domain.
    Kobayashi E; Shimizu R; Kikuchi Y; Takahashi S; Yamamoto M
    J Biol Chem; 2010 Jan; 285(1):773-83. PubMed ID: 19854837
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Efficacy of Co-transplantation of Hematopoietic Stem Cells Combined With Human Umbilical Cord-Derived Mesenchymal Stem Cells in Children With Severe Aplastic Anemia: A Single-Center Experience.
    Akçay A; Atay D; Erbey F; Akıncı B; Demir Yenigürbüz F; Eyüboğlu F; Ovalı E; Öztürk G
    Exp Clin Transplant; 2022 Dec; 20(12):1114-1121. PubMed ID: 34142939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.